Psychoactive Medications in the Long-Term Care Setting: Differing Perspectives among Physicians,Nursing Staff,and Patients

Abstract

Differences in perceptions among nursing home patients, nursing staff, and physicians were compared in this preliminary study regarding nighttime disorders and psychoactive medications. Nighttime disorders, including both insomnia and behavior problems, are prevalent among institutionalized elderly and are frequently managed with psychoactive medications. All nursing home patients receiving psychoactive medications, the nursing staff, and the physicians involved in their care were interviewed regarding the description, etiology, management, and impact of the nighttime disorder including side effects of the prescribed medications. Overall, the differences in responses among the three groups ranged from 47% to 63%. While both physicians and nurses reported problems more often than did the patients, nurses reported problems more frequently than did physicians. This preliminary study suggests that patients, nursing staff, and physicians perceive nighttime disorders and their management differently. These differences point to the need for improved methods of communication and education to mutually identify the targeted disorder and develop appropriate management.

Get full access to this article

View all access options for this article.

References

1. Rubenstein LZ , Schairer C , Wieland GD , Kane R. Systematic biases in functional status assessment of elderly adults: effects of different data sources. J Gerontol 1984; 39:686–691.

2. Cohen D , Eisdorfer C , Prinz P , et al. Sleep disturbances in the institutionalized aged. J Am Geriatr Soc 1983; 31:79–82.

3. Karacan I , Thornby JI , Anch M , et al. Prevalence of sleep disturbance in a primarily urban Florida county. Soc Sci Med 1976; 10:239–244.

4. Zimmer JG , Watson N , Treat A. Behavioral problems among patients in skilled nursing facilities. Am J Public Health 1984; 74:1118–1121.

5. Raskin E. Antipsychotic medication and the elderly. J Clin Psychol 1985; 46:36–40.

6. Avorn J , Dreyer P , Connelly K , et al. Use of psychoactive medication and the quality of care in rest homes: findings and policy implications of a statewide study. N Engl J Med 1989; 320: 227–232.

7. Beers M , Avorn J , Soumerai SB , et al. Psychoactive medication use in intermediate-care facility residents. J Am Med Assoc 1988; 260:3016–3020.

8. Buck JA . Psychotropic drug practice in nursing homes. J Am Geriatr Soc 1988; 36:409–418.

9. Nolan L , O'Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age Aging 1989; 18:52–56.

10.

10. Barnes R , Veith R , Okimoto J , et al. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am J Psychol 1982; 139:1170–1174.

11.

11. Beardsley RS , Larson DB , Burns BJ , et al. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989; 37:327–330.

12.

12. Covert A , Rodriges T , Solomon K. The use of mechanical and chemical restraints in nursing homes. J Am Geriatr Soc 1977; 25:85–89.

13.

13. Helms PM . Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature. J Am GeriatrSoc 1985; 33:206–209.

14.

14. Kales A , Bixler EO , Tan TL , et al. Chronic hypnotic use: ineffectiveness, drug withdrawal insomnia, and hypnotic drug dependence. J Am Med Assoc 1974; 227:513–517.

15.

15. Folstein MF , Folstein SE , McHugh PR . “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198.

16.

16. Katz S , Downs TD , Cash HR , et al. Progress in development of the index of ADL. Gerontologist 1970; 10:20–30.

17.

17. Brody EM , Kleban MH . Physical and mental health symptoms of older people: Who do they tell? J Am Geriatr Soc 1981; 29:442–449.

18.

18. Svanborg A. The health of the elderly population: results from longitudinal studies with age-cohort comparisons. In: Evered D , Whelan J , Eds. Research and the aging population. Chichester, UK: John Wiley & Sons, 1988.

19.

19. Williamson J , Stokoe HI , Gray S , et al. Old people at home: their unreported needs. Lancet 1964; 5:1117–1120.

20.

20. Beers MH , Ouslander JG , Fingold SF , et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Int Med 1992; 17:684–689.

21.

21. Smith L. Aging and drug response: research priorities and future directions. In: Jarvik L , Greenblatt DJ , Harman D , Eds. Clinical pharmacology and the aged patient. New York: Raven Press, 1981.

22.

22. Ray WA , Griffin MR , Schaffner W , et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–369.

23.

23. Rovner BW , German PS , Brant W , et al. Depression and mortality in nursing homes. JAMA 1991; 265:993–996.

24.

24. Heston LL , Garrard J , Makris L , et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992; 40:1117–1122.

25.

25. Butler FR , Burgio L , Engel BT . Neuroleptics and behavior: a comparative study. J Gerontol Nursing 1987; 13:15–19.

26.

26. Risse SC , Barnes R. Pharmacologic treatment of agitation associated with dementia. J Am Geriatric Soc 1986; 34:368–376.